Solvemed to advance neuro-ocular biomarker tech with latest raise
Solvemed announced Tuesday that it raised $3.5 million to help build out an artificial intelligence-based ocular biomarker engine that it hopes will enable portable diagnosis of neurological diseases using the eye as a window into the brain.